Skip to main content

ORTHOFIX International N V Value Stock - Dividend - Research Selection

Orthofix international n v

ISIN: US68752M1080 , WKN: A2NB0X

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Orthofix International N.V., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. Orthofix International N.V. was founded in 1987 and is headquartered in Lewisville, Texas.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18

2026-05-22
Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $20 to $18.

Chevron To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Friday

2026-05-22
Get the latest analyst rating changes for top companies on Wall Street, including upgrades and downgrades. View complete details at Benzinga.

Barrington Research Maintains Outperform on Orthofix Medical, Lowers Price Target to $15

2026-05-22
Barrington Research analyst Michael Petusky maintains Orthofix Medical (NASDAQ:OFIX) with a Outperform and lowers the price target from $17 to $15.

Stifel Maintains Buy on Orthofix Medical, Lowers Price Target to $15

2026-05-22
Stifel analyst Thomas Stephan maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $18 to $15.

Orthofix to Participate in Upcoming Investor Conferences

2026-05-18
Orthofix Medical Inc. , a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences:Goldman Sachs 47th Annual Global...

Orthofix Medical Inc. 2026 Q1 - Results - Earnings Call Presentation

2026-05-07
2026-05-07. The following slide deck was published by Orthofix Medical Inc.

Orthofix Medical Announces New Pediatric Limb Reconstruction Innovations That Expand Treatment Options For Pediatric And Small Stature Patients

2026-05-06
The Company will highlight these advances at the Pediatric Orthopedic Society of North America (POSNA) 2026 Annual Meeting, which takes place May 6-8, 2026, at the Rosen Shingle Creek Hotel in Orlando, Florida.At POSNA

Orthofix Expands Pediatric Limb Reconstruction Portfolio with New FITBONE™ Innovation at POSNA 2026 Annual Meeting

2026-05-06
Orthofix Medical Inc. , a leading global medical technology company, today announced new pediatric limb reconstruction innovations that expand treatment options for pediatric and small stature...

Halper Sadeh LLC Encourages Orthofix Medical Inc. Shareholders to Contact the Firm to Discuss Their Rights

2026-05-05
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Shareholders are encouraged to contact the firm at no cost or obligation. We would handle any...

Orthofix Medical Inc. (NASDAQ:OFIX) Reports Mixed Q1 as Sales Miss Estimates, Loss Narrows; Full-Year Outlook Reaffirmed

2026-05-05
Orthofix Q1 revenue of $196.7M missed estimates, but net loss narrowed to $(0.52) per share. Full-year 2026 outlook reaffirmed despite shares falling 4% in pre-market trading.